Amount of antibody produced by COVID-19 vaccination of mRNA-1273(Takeda/Moderna) and BNT162b2(Pfizer/BioNTech) in Japanese youth.
Latest Information Update: 01 Apr 2022
At a glance
- Drugs Elasomeran (Primary) ; Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Pharmacodynamics
- 25 Mar 2022 Status changed from not yet recruiting to active, no longer recruiting.
- 28 Sep 2021 New trial record